skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Find Out More

State of the Industry 2019:

KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables.

The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.

Who completed the survey?

214 clinical trials professionals from within pharma and biotech (28%), CROs (29%), service providers, consultancies and medical device companies (26%), investigator sites (6%) and academia (4%) responded to the survey. The majority of respondents were from Europe (66%) followed by North America (17%) and Asia (13%).








電話:+81 (0)3 6273 4260